Tag Archives: Giving

Sandoz’s Enbrel biosim case turned away at SCOTUS, giving Amgen’s blockbuster 8 more years of free rein

After back-to-back losses in court, Novartis’ generics outfit Sandoz had hoped the U.S. Supreme Court would take up its long shot biosimilars case against Enbrel maker Amgen. But now that effort has failed, giving Amgen a clear path to many more years of blockbuster sales for its top drug.  The U.S. Supreme Court denied taking up Sandoz’s petition… Read More »

Medical News Today: Giving TB vaccine intravenously boosts efficacy

Experiments in rhesus macaques show that changing the mode of administration of an existing vaccine yields “amazing” results in the fight against tuberculosis (TB). Share on PinterestDelivering the TB vaccine intravenously rather than intradermally may prove significantly more effective. Globally, TB is one of the top 10 causes of death and the leading cause of… Read More »